9th - 10th September, Cambridge, UK
More informationJoin the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationDraft Guidance Released
Draft Guidance Released
The U.S. Food and Drug Administration is advancing its mission of ensuring the public has access to accurate, up-to-date science-based information to inform decisions about FDA-regulated medical products to maintain and improve their health.
Announced for Thursday, 28 November 2024.
MHRA have released information about procurement at the Agency and how they are improving procurement opportunities for small and medium-sized enterprises.
The first global open access clearing house for information on medical devices.
WHO recently issued updated guidance for national authorities and biomedical laboratories to manage biological risks.
A report by European Federation of Pharmaceutical Industries and Associations
Open for comment now.
ICH M14 Guideline on General Principles on Plan, Design, and Analysis of Pharmacoepidemiological Studies that Utilize Real-World Data for Safety Assessment of Medicines.